Literature DB >> 22262757

Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Srini V Kaveri1, Gregg J Silverman, Jagadeesh Bayry.   

Abstract

Natural IgM Abs are the constitutively secreted products of B1 cells (CD5(+) in mice and CD20(+)CD27(+)CD43(+)CD70(-) in humans) that have important and diverse roles in health and disease. Whereas the role of natural IgM as the first line of defense for protection against invading microbes has been extensively investigated, more recent reports have highlighted their potential roles in the maintenance of tissue homeostasis via clearance of apoptotic and altered cells through complement-dependent mechanisms, inhibition of inflammation, removal of misfolded proteins, and regulation of pathogenic autoreactive IgG Abs and autoantibody-producing B cells. These observations have provided the theoretical underpinnings for efforts that currently seek to harness the untapped therapeutic potential of natural IgM either by boosting in vivo natural IgM production or via therapeutic infusions of monoclonal and polyclonal IgM preparations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262757      PMCID: PMC3266110          DOI: 10.4049/jimmunol.1102107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

Review 1.  Natural autoantibodies as tools to predict the outcome of immune response?

Authors:  H Kohler; J Bayry; A Nicoletti; S V Kaveri
Journal:  Scand J Immunol       Date:  2003-09       Impact factor: 3.487

2.  CD22 serves as a receptor for soluble IgM.

Authors:  Takahiro Adachi; Satoru Harumiya; Hiromu Takematsu; Yasunori Kozutsumi; Matthias Wabl; Manabu Fujimoto; Thomas F Tedder
Journal:  Eur J Immunol       Date:  2011-11-10       Impact factor: 5.532

3.  Phosphorylcholine-targeting immunization reduces atherosclerosis.

Authors:  Giuseppina Caligiuri; Jamila Khallou-Laschet; Marta Vandaele; Anh-Thu Gaston; Sandrine Delignat; Chantal Mandet; Heinz V Kohler; Srini V Kaveri; Antonino Nicoletti
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

4.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

5.  De novo development and self-replenishment of B cells.

Authors:  A B Kantor; A M Stall; S Adams; K Watanabe; L A Herzenberg
Journal:  Int Immunol       Date:  1995-01       Impact factor: 4.823

6.  IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.

Authors:  Taraneh Mehrani; Michelle Petri
Journal:  J Rheumatol       Date:  2010-12-01       Impact factor: 4.666

Review 7.  Generation, expansion, migration and activation of mouse B1 cells.

Authors:  S Fagarasan; N Watanabe; T Honjo
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

8.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

9.  Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.

Authors:  Rekha R Rapaka; David M Ricks; John F Alcorn; Kong Chen; Shabaana A Khader; Mingquan Zheng; Scott Plevy; Eva Bengtén; Jay K Kolls
Journal:  J Exp Med       Date:  2010-12-13       Impact factor: 14.307

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more
  55 in total

Review 1.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature.

Authors:  Zita Chovancova; Pavlina Kralickova; Alena Pejchalova; Marketa Bloomfield; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2017-07-21       Impact factor: 8.317

Review 3.  Polyreactive Antibodies: Function and Quantification.

Authors:  Sreenivasulu Gunti; Abner Louis Notkins
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

Review 4.  Hematopoietic stem cell-independent hematopoiesis and the origins of innate-like B lymphocytes.

Authors:  Eliver Ghosn; Momoko Yoshimoto; Hiromitsu Nakauchi; Irving L Weissman; Leonore A Herzenberg
Journal:  Development       Date:  2019-08-01       Impact factor: 6.868

Review 5.  The Role of the Thymus in the Immune Response.

Authors:  Puspa Thapa; Donna L Farber
Journal:  Thorac Surg Clin       Date:  2019-03-07       Impact factor: 1.750

6.  GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.

Authors:  Leo Rasche; Johannes Duell; Inês C Castro; Valentina Dubljevic; Manik Chatterjee; Stefan Knop; Frank Hensel; Andreas Rosenwald; Hermann Einsele; Max S Topp; Stephanie Brändlein
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

Review 7.  Protective autoantibodies in the rheumatic diseases: lessons for therapy.

Authors:  Gregg J Silverman; Jaya Vas; Caroline Grönwall
Journal:  Nat Rev Rheumatol       Date:  2013-03-19       Impact factor: 20.543

Review 8.  Regulatory functions of innate-like B cells.

Authors:  Xiaoming Zhang
Journal:  Cell Mol Immunol       Date:  2013-02-11       Impact factor: 11.530

9.  Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice.

Authors:  Smita Jaiswal; Kenneth Smith; Alejandro Ramirez; Marcia Woda; Pamela Pazoles; Leonard D Shultz; Dale L Greiner; Michael A Brehm; Anuja Mathew
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

10.  Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.

Authors:  Derek D Jones; Gregory A DeIulio; Gary M Winslow
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.